WA
ARGS

Wasatch Advisors’s Argos Therapeutics, Inc. ARGS Stock Holding History

Wasatch Advisors’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-32,163
Closed -$96K – 322
2017
Q4 		$96K Sell
32,163
-1,129
-3% -$3.79K ﹤0.01% 293
2017
Q3 		$120K Buy
+33,292
New +$160K ﹤0.01% 324
2017
Q2 		– Sell
-9,345
Closed -$85K – 365
2017
Q1 		$85K Sell
9,345
-153,366
-94% -$9.71M ﹤0.01% 344
2016
Q4 		$15.9M Buy
162,711
+1,274
+0.8% +$119K 0.24% 85
2016
Q3 		$16M Buy
161,437
+42,013
+35% +$4.39M 0.24% 97
2016
Q2 		$14.6M Sell
119,424
-943
-0.8% -$126K 0.22% 106
2016
Q1 		$18.9M Buy
120,367
+6,557
+6% +$530K 0.29% 92
2015
Q4 		$5.26M Sell
113,810
-1,126
-1% -$95.2K 0.07% 211
2015
Q3 		$11.1M Buy
114,936
+7,784
+7% +$922K 0.15% 152
2015
Q2 		$14.7M Sell
107,152
-1,430
-1% -$228K 0.16% 155
2015
Q1 		$19.3M Buy
108,582
+35,796
+49% +$6.23M 0.2% 130
2014
Q4 		$14.6M Buy
72,786
+14,869
+26% +$2.67M 0.15% 146
2014
Q3 		$11.7M Sell
57,917
-4,193
-7% -$655K 0.12% 169
2014
Q2 		$9.97M Buy
62,110
+239
+0.4% +$39.5K 0.1% 203
2014
Q1 		$12.4M Buy
+61,871
New +$12.4M 0.12% 186

Other funds holding ARGS

PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Wasatch Advisors's ARGS Position: Q1 2018 in Review

Wasatch Advisors sold out of Argos Therapeutics, Inc. (ARGS) in Q1 2018, closing a stake of 32,163 shares — an estimated $96K sold.

Wasatch Advisors first reported a position in ARGS in Q1 2014 and held it in 15 quarters. The position peaked at $19.3M in Q1 2015. 16 funds tracked by Wall St. Rank hold ARGS as of Q1 2018.

  • Wasatch Advisors reported no remaining Argos Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Wasatch Advisors sold 32,163 Argos Therapeutics, Inc. shares in Q1 2018, an estimated $96K.
  • Wasatch Advisors first reported a position in Argos Therapeutics, Inc. in Q1 2014 and held it in 15 quarters.
  • Wasatch Advisors's Argos Therapeutics, Inc. position peaked at $19.3M in Q1 2015.
  • 16 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q1 2018.

Based on Wasatch Advisors's 13F filing for Q1 2018, filed 2 May 2018.